Module 3 Part 2
Module 3 Part 2
MODULE 3
The FEV1/FVC Ratio (FEV1%) parameter is calculated by dividing the measured FEV1 value by the
measured FVC value.
The Measured column shows the absolute (numerical) ratio, and the
Predicted column shows the ratio expressed as a percentage.
In healthy adults of the same gender, height, and age, the normal Predicted percentage should be between
70% and 85%
16
TYPES OF VENTILATORS
Negative-pressure ventilators
Positive-pressure ventilators.
24 Negative-Pressure Ventilators
Early negative-pressure ventilators were known as “Iron lungs.”
The patient’s body was encased in an iron cylinder and negative
pressure was generated .
The iron lung are still occasionally used today.
Intermittent short-term negative-pressure ventilation is
sometimes used in patients with chronic diseases.
The use of negative-pressure ventilators is restricted in clinical
practice, however, because they limit positioning and movement
and they lack adaptability to large or small body torsos (chests).
Our focus will be on the positive-pressure ventilators.
25 Positive-pressure ventilators
Positive-pressure ventilators deliver gas to the patient under positive-pressure, during the
inspiratory phase.
31 Artificial lungs are devices designed to mimic the function of
the natural respiratory system. They are used to support
patients with acute respiratory distress syndrome (ARDS) or
acute lung injury (ALI) and to help the patient's own lungs
recover and heal.
Types
There are two main types of artificial lungs: membrane
oxygenators and extracorporeal lung assist devices.
Membrane Oxygenators: These are devices that use a
semipermeable membrane to transfer oxygen and carbon
dioxide between the blood and the air. The blood is pumped
through the membrane, where it comes into contact with air,
allowing for the exchange of gases.
Extracorporeal Lung Assist Devices: These devices work by
removing carbon dioxide from the blood and adding oxygen,
allowing the patient's natural lungs to rest and heal. One
example of an extracorporeal lung assist device is the
extracorporeal membrane oxygenation (ECMO) machine,
which is used to treat patients with severe respiratory failure.
ECMO works by removing carbon dioxide from the blood and
adding oxygen, and it can be used as a bridge to recovery or
as a bridge to lung transplantation.
KIDNEY AS FILTRATION SYSTEM:
32
The kidney is a complex organ that acts as a filtration system for the body. It
removes waste and excess fluid from the bloodstream and maintains a
delicate balance of electrolytes, hormones, and other substances that are
critical for the body's normal functioning.
The kidney also plays an important role in regulating blood pressure by
secreting the hormone renin, which helps control the balance of fluid and
electrolytes in the body. It also regulates red blood cell production and the
levels of various minerals in the blood, such as calcium and phosphorus.
Without the kidney, waste and excess fluid would accumulate in the body,
leading to serious health problems.
33
Kidneys remove wastes and extra fluid from the body.
Kidneys also remove acid that is produced by the cells
of the body
Kidney maintain a healthy balance of water, salts, and
minerals—such as sodium, calcium, phosphorus, and
potassium—in the blood.
Without this balance, nerves, muscles, and other
tissues in the body may not work normally.
Kidneys also make hormones that help
Control blood pressure.
Make red blood cells NIH external link.
Keeps bones strong and healthy
Architecture of Kidney
34
Hemodialysis is a procedure
that uses a machine to clean
the blood. During
hemodialysis, blood is removed
from the body, passed through
a dialysis machine that filters
out waste and excess fluids,
and then returned to the body.
Hemodialysis typically takes
place in a hospital or dialysis
center, and is typically
performed three times a week
for three to four hours at a
time.
43
Peritoneal dialysis is a type of
dialysis that uses the lining of the
abdomen, called the peritoneum,
to filter waste and excess fluids
from the blood. A sterile solution
is introduced into the abdomen,
where it absorbs waste and
excess fluids, and is then drained
and replaced with fresh solution.
Peritoneal dialysis can be
performed at home and allows for
more flexibility in scheduling.
Artificial Kidney
While much progress has been made in developing an artificial
44 kidney, it is still in the experimental stage and is not yet widely
available. Further research and development is needed to improve
the efficiency and safety of artificial kidney devices, and to ensure
that they can be widely adopted as a treatment for chronic kidney
disease.
An artificial kidney is a device that is being developed to mimic the
functions of the human kidney. The goal of an artificial kidney is to
provide a more effective and efficient means of treating patients with
chronic kidney disease, who currently rely on dialysis or kidney
transplantation.
There are currently two main approaches to developing an artificial
kidney: a biological approach and a technological approach.
The biological approach involves using living cells, such as kidney
cells or stem cells, to create a functional, implantable artificial kidney.
The technological approach involves using synthetic materials, such
as silicon or polymer, to create a dialysis device that can filter the
blood and remove waste and excess fluids.
It's important to note that while the development of an artificial
kidney holds great promise, it is not a cure for chronic kidney disease
and patients with kidney failure will still need dialysis or kidney
transplantation in the meantime.
45 Muscular Systems as Scaffolds
The use of muscular systems as scaffolds in regenerative medicine is an area of active
research and development. Muscles have the potential to be used as scaffolds for the
regeneration of tissues due to their inherent mechanical properties and ability to support cell
growth and tissue formation.
One example of using muscular systems as scaffolds is in the treatment of damaged or
diseased heart tissue. Researchers have developed methods for using muscle cells to
create a functional, three-dimensional scaffold that can support the growth of new heart
tissue. In this approach, muscle cells are harvested from the patient and then seeded onto a
scaffold, such as a hydrogel or artificial matrix. The scaffold provides a framework for the
cells to grow and differentiate into new heart tissue, which can help to repair the damaged
or diseased tissue.
Another example is in the treatment of skeletal muscle injuries, such as those caused
by trauma or disease. In this case, muscle cells can be harvested and seeded onto a
scaffold, which can then be implanted into the damaged muscle to promote the growth of
new, functional tissue.
While the use of muscular systems as scaffolds is still in the experimental stage, it holds
great promise for the treatment of a variety of conditions and represents an area of active
research and development in the field of regenerative medicine
Architecture
46
Inside each skeletal muscle, muscle fibers are
organized into bundles, called fascicles,
surrounded by a middle layer of connective tissue
called the perimysium. This fascicular organization
is common in muscles of the limbs; it allows the
nervous system to trigger a specific movement of a
muscle by activating a subset of muscle fibers
within a fascicle of the muscle. Inside each fascicle,
each muscle fiber is encased in a thin connective
tissue layer of collagen and reticular fibers called
the endomysium. The endomysium surrounds the
extracellular matrix of the cells and plays a role in
transferring force produced by the muscle fibers to
the tendons.
Inside the muscle fibers, there are tiny structures
called myofibrils. Myofibrils are made up of smaller
units called sarcomeres, which are responsible for
muscle contraction.
47
Sarcomeres contain thin (Actin) and thick filaments
(Myosin) that work together to make the muscle fibers
contract. Each muscle fiber is surrounded by a
protective layer called endomysium. Multiple muscle
fibers are grouped together into bundles called
fascicles. Fascicles are surrounded by another layer of
connective tissue called perimysium.
All the fascicles together make up the entire muscle,
which is surrounded by a layer called epimysium. The
muscle also has a special membrane called the
sarcolemma, which protects the muscle fiber. Inside
the muscle fiber, there are small tunnels called T-
tubules that help transmit signals for muscle
contraction. Muscles work through the coordination of
motor units, which consist of a motor neuron and the
muscle fibers it controls. This architecture allows
muscles to generate force, move our bodies, and
perform various activities.
MECHANISM
48
The nervous system (your body’s command center) controls your voluntary
muscle movements. Voluntary muscles are ones you control intentionally.
Some involve large muscle groups to do activities like jumping. Others use
smaller movements, like pushing a button.
Movements happen when nervous system (brain and nerves) sends a message
to activate your skeletal (voluntary) muscles.Our muscle fibers contract (tense
up) in response to the message.
When the muscle activates or bunches up, it pulls on the tendon. Tendons
attach muscles to bones. The tendon pulls the bone, making it move.
To relax the muscle, your nervous system sends another message, It triggers
the muscles to relax or deactivate.
The relaxed muscle releases tension, moving the bone to a resting position.
Hundreds of conditions can cause problems with the musculoskeletal system.
They can affect the way you move, speak and interact with the world.
The mechanism of how the muscular system can be used as a scaffold in regenerative
49
medicine involves the use of muscle cells and a scaffold to support the growth and
regeneration of new tissue.
The method of growing muscle tissue using hydrogel or artificial scaffold is explained
below:
The basic steps in this process are as follows:
Harvesting of muscle cells: Muscle cells are typically obtained from the patient and
then isolated and expanded in culture.
Seeding onto scaffold: The muscle cells are then seeded onto a scaffold, such as a
hydrogel or artificial matrix. The scaffold provides a framework for the cells to grow
and differentiate into new tissue.
Cell differentiation and tissue formation: Once the cells are seeded onto the scaffold,
they undergo differentiation, in which they change into specific cell types, such as
muscle cells or heart cells. The cells also begin to organize and form new tissue, such
as heart tissue or skeletal muscle tissue.
Implantation into patient: The scaffold and cells are then implanted into the patient to
promote the growth of new, functional tissue.
50
Muscle cells can be used as a scaffold for tissue generation by removing the living cells from the muscle
51
tissue, leaving behind the structure known as the extracellular matrix (ECM). This decellularized muscle
scaffold provides a framework that can guide and support the growth of new tissues.
The Process
Harvesting muscle tissue: A small sample of muscle tissue is taken, typically from a donor or an
animal model.
Cell removal: The living cells within the muscle tissue are removed using a process called
decellularization. This involves treating the tissue with specific chemical solutions or enzymes
that break down and wash away the cellular components, while preserving the ECM.
ECM scaffold: The remaining ECM, which forms the structure of the muscle, is now a scaffold. It
consists of proteins, such as collagen and elastin, and other molecules that provide support and
signals for tissue growth.
Seeding cells: The decellularized muscle scaffold is then seeded with desired cells. These can be
stem cells or specialized cells relevant to the type of tissue being regenerated. The cells are
introduced onto the scaffold, allowing them to attach and populate the structure.
Tissue growth: Over time, the seeded cells proliferate and differentiate, meaning they multiply
and transform into specific cell types required for the desired tissue. The ECM scaffold guides the
cells' growth, providing physical support, and biochemical cues to influence their behavior.
Tissue integration: As the cells continue to grow, they populate the scaffold and form new tissue.
The new tissue integrates with the surrounding native tissue, gradually replacing the
decellularized scaffold with functional, regenerated tissue.
By utilizing the decellularized muscle scaffold, the process of tissue generation takes advantage of the
existing three-dimensional architecture and mechanical properties of the muscle. This approach has the
potential to address challenges in tissue engineering, such as creating a suitable environment for cell growth,
promoting vascularization, and facilitating functional integration of regenerated tissues.
Muscular Dystrophy
Muscular dystrophy is a group of genetic disorders that result in progressive
52
weakness and degeneration of the skeletal muscles, which are responsible
for movement.
The disorders are caused by mutations in genes that encode proteins needed for
muscle function.
The most common type of muscular dystrophy is Duchenne muscular dystrophy,
which typically affects young boys and leads to severe disability by early adulthood.
Other forms of the disease include Becker muscular dystrophy, limb-girdle
muscular dystrophy, and facioscapulohumeral dystrophy, among others.
There is currently no cure for muscular dystrophy, but various treatments can help
manage symptoms and slow the progression of the disease. These may include
physical therapy, assistive devices, orthopedic surgery, and medication to
manage muscle spasms and pain. In some cases, genetic therapy and stem
cell transplantation are also being explored as potential treatment options.
It's important for individuals with muscular dystrophy to work closely with a
healthcare team that includes specialists in neurology, rehabilitation medicine, and
orthopedics, to develop a comprehensive care plan that meets their specific needs.
53 Duchenne muscular dystrophy (DMD) usually appears early in
childhood between the ages of 2 and 3. DMD primarily affects boys but
can affect girls in rare cases. The primary symptom of DMD is muscle
weakness that begins in the muscles close to the body and later affects
muscles in the outer limbs.
Becker muscular dystrophy typically becomes apparent between the
ages of 5 and 15. It is similar to Duchenne MD, except that it progresses
slower and symptoms begin to appear later. Boys are primarily affected
by Becker MD. Becker MD causes muscle loss that begins in the hips and
pelvic area, thighs, and shoulders.
The age of onset of limb-girdle muscular dystrophy is highly varied,
ranging from early childhood to later adulthood. The disease is
characterized by muscle weakness and atrophy of the muscles of the
hip and shoulder areas (the limb girdles).
Facioscapulohumeral dystrophy (FSHD) typically appears before the
age of 20, but can appear later in adulthood or even in childhood in both
males and females. FSHD affects the muscles of the face, around the
shoulder blades, and in the upper arms.
Bioengineering solutions for muscular dystrophy
54
Bioengineering solutions for muscular dystrophy aim to improve the lives of
individuals affected by the disease by addressing the underlying genetic mutations
and muscle weakness. Some of the approaches being explored include:
Gene therapy: This involves delivering a functional copy of the missing or mutated
gene to the affected muscle cells. The goal is to restore the production of the missing
protein and improve muscle function.
Stem cell therapy: This involves using stem cells to replace the damaged muscle
cells and promote repair and regeneration of the muscle tissue. Stem cells can be
taken from the patient's own body (autologous stem cells) or from a donor (allogenic
stem cells).
Exoskeleton technology: This involves using wearable devices, such as robotic
exoskeletons, to support and enhance the movement of individuals with muscular
dystrophy. The devices use motors and sensors to mimic the movements of the
wearer and help improve mobility.
Tissue engineering: This involves using a combination of materials, such as
scaffolds and growth factors, to promote the growth and repair of muscle tissue. The
goal is to create functional muscle tissue that can replace the damaged tissue in
individuals with muscular dystrophy.
These approaches are still in the early stages of development, but hold promise for
the future treatment of muscular dystrophy. Clinical trials and further research are
Artificial Muscles
55
Artificial muscle refers to a type of technology that aims to mimic the properties and
functions of natural muscle. Artificial muscles can be made from various materials,
including shape memory alloys, electroactive polymers, and carbon nanotubes.
Polymers:
Polymers used in artificial bone applications offer flexibility, versatility, and the
ability to customize their properties. Some examples include:
Polycaprolactone (PCL): PCL is a biodegradable polymer with good mechanical
properties. It is often used in bone tissue engineering scaffolds due to its slow
degradation rate, allowing it to provide support during the regeneration process.
Poly(lactic-co-glycolic acid) (PLGA): PLGA is a biocompatible and biodegradable
polymer composed of lactic acid and glycolic acid units. It has been extensively
used in various medical applications, including bone tissue engineering. PLGA
scaffolds can be tailored to degrade at a desired rate, enabling synchronized new
tissue formation.
Polyethylene Glycol (PEG): PEG is a hydrophilic polymer that can be modified to
create scaffolds with specific properties. It can be combined with other materials,
such as ceramics, to enhance their mechanical strength and bioactivity. PEG-
based hydrogels and composites have shown promise for bone tissue
engineering.
68
Advantages
Artificial bones can be used to treat a variety of conditions, including osteoporosis, bone fractures,
and congenital conditions that result in missing or malformed bones. Some of the advantages of
artificial bones include:
Durability: Artificial bones can be made from materials that are more durable than natural bone,
making them more resistant to fractures and other forms of damage.
Customization: Artificial bones can be designed and manufactured to fit a specific patient's
needs, taking into account factors such as size, shape, and bone quality.
Reduced risk of rejection: Unlike natural bone, which can be rejected by the body, artificial
bones are made from biocompatible materials that are less likely to cause an immune response.
Faster recovery: Artificial bones can often be implanted more quickly than natural bone grafts,
which can lead to faster healing and rehabilitation.
However, there are also some potential drawbacks to artificial bones, such as the risk of implant
failure, long-term stability issues, and the need for additional surgeries in the case of implant wear
or damage. Overall, artificial bones are a promising technology that can provide a range of
benefits to patients with damaged or missing bones. However, further research is needed to fully
understand their safety and efficacy, and to develop new and improved artificial bone implants
69